Eva M. Kemper

Pharmacokinetics and Absolute Bioavailability of Selegiline Following Treatment of Healthy Subjects With the Selegiline Transdermal System (6 mg/24 h): A Comparison With Oral Selegiline Capsules

Albert J. Azzaro, John A. Ziemniak, Eva M. Kemper et al. · The Journal of Clinical Pharmacology · 2007 · 60 citations

Translational Medicine, Oral Selegiline Capsules, Healthy Subjects +8

Tyramine Pharmacokinetics and Reduced Bioavailability with Food

Chad M. VanDenBerg, Lawrence F. Blob, Eva M. Kemper et al. · The Journal of Clinical Pharmacology · 2003 · 49 citations

Nutrition, Tyramine Elimination Half-life, Tyramine Challenge Studies +9

Tyramine Pressor Sensitivity During Treatment With the Selegiline Transdermal System 6 mg/24 h in Healthy Subjects

Albert J. Azzaro, Chad M. VanDenBerg, Lawrence F. Blob et al. · The Journal of Clinical Pharmacology · 2006 · 45 citations

Effects of a Tyramine-Enriched Meal on Blood Pressure Response in Healthy Male Volunteers Treated with Selegiline Transdermal System 6 mg/24 Hour

Lawrence F. Blob, Melvin Sharoky, Eva M. Kemper et al. · CNS Spectrums · 2007 · 25 citations

Evaluation of the Potential for Pharmacodynamic and Pharmacokinetic Drug Interactions Between Selegiline Transdermal System and Two Sympathomimetic Agents (Pseudoephedrine and Phenylpropanolamine) in Healthy Volunteers

Albert J. Azzaro, Chad M. VanDenBerg, John A. Ziemniak et al. · The Journal of Clinical Pharmacology · 2007 · 16 citations

Hypertension, Psychotropic Medication, Cardiovascular Pharmacology +16